Summary

Jefferies & Company, Inc. (Jefferies) is a global securities and investment banking company. It operates as a subsidiary of Jefferies Group, Inc. It offers institutional brokerage, capital market and financial advisory services, securities research and wealth and asset management services to high net worth individual, institutional investor and corporate clients. Jefferies provides advisory services in the field of mergers and acquisitions, equity and equity-linked financing, leveraged finance, and restructuring solutions. It caters to various industries such as energy, aerospace and defense, business services, gaming and leisure, industrials, healthcare, lodging and real estate, maritime, media, technology and telecommunications. The company has operations across the US and one representative office in China. Jefferies is headquartered in New York, the US.

GlobalData’s Jefferies & Company, Inc. (JEF) - Medical Equipment - Advisory Profile provides an overview of the deals advised by Jefferies & Company, Inc. in the Medical Devices market. The report is an essential source of information for Medical Devices companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Jefferies & Company, Inc.'s deals for the past five years segregated into year, deal type, segment and geography.

Scope

- Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
- Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
- Analyzes the advisor’s deals by year, deal type, segment and geography
- Provides detailed information on deal particulars, including information about other advisors involved in the deal
- Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
- Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
- Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies).

Reasons to Buy

- Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
- Peruse all the advisor’s deals in the Industry market
- Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
- Identify other potential advisors currently active in your industry, or industry that you wish to foray into
- Compare your advisory services vis-à-vis your competitors’
- Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
- Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Jefferies and Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 8
Jefferies and Company, Inc., Medical Equipment Deals Advised By Type, 2007 to YTD 2013 9
Jefferies and Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 10
Jefferies and Company, Inc., Medical Equipment Deals Advised By Market, 2007 to YTD 2013 11
Jefferies and Company, Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 13
Jefferies and Company, Inc., Medical Equipment, Deal Details 20
Acquisition 20
Sonova Holding Acquires Advanced Bionics 20
AMICAS Acquires Emageon 22
Baxter International Completes Acquisition Of Baxa For US$380 Million 23
Align Technology Completes Acquisition Of Cadent 25
Covidien Completes Acquisition Of Power Medical Interventions 28
Berwind Acquires Oliver Products, Developer Of Sterile Medical Device, From Mason Wells 30
Tunstall Healthcare Completes Acquisition Of American Medical Alert For US$82 Million 31
BioScrip Completes Acquisition Of Critical Homecare Solutions From Kohlberg and Company 33
MedAssets Completes The Acquisition Of Broadlane From TowerBrook 35
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 37
Baxter International Completes Acquisition Of Prism Pharma For US$338 Million 39
MedQuist And Cbay Complete The Acquisition Of Spheris 41
Nuance Communications Acquires eScription 43
Bausch and Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 45
Myriad Genetics Acquires Rules-Based Medicine 47
Philips Healthcare Acquires Discus Holdings 49
Dainippon Sumitomo Pharma Completes Acquisition Of Sepracor For US$2.6 Billion 50
General Dynamics Acquires ViPs From HLTH 52
AssuraMed Completes Acquisition Of Invacare Supply Group From Invacare For US$151 Million 53
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 55
Hologic Acquires Cytyc For US$6,200 Million 57
Roper Industries Completes Acquisition Of Sunquest Information Systems, Healthcare IT Company, For US$1.42 Billion 59
Pall Corporation Completes Acquisition Of ForteBio For US$142.5 Million 61
Hologic Acquires Biolucent 63
Automatic Data Processing Acquires AdvancedMD 64
The ConJoin Group Acquires PHNS 66
3M Company Completes Acquisition Of Arizant From Court Square Capital 67
Asset Transactions 69
Kimberly-Clark Completes Acquisition Of Pain Management Business From Baylis Medical Company 69
Trinity Biotech Completes Sale Of Coagulation Business To Diagnostica Stago 70
Debt Offerings 72
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For US$200 Million 72
Teleflex Completes Underwritten Public Offering Of 3.875% Convertible Senior Subordinated Notes For US$400 Million 73
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2017 For US$500 Million 75
RadNet Completes Private Placement Of 10.375% Senior Unsecured Notes For US$200 Million 77
Inverness Medical Innovations Completes Private Placement Of Senior Notes For US$100 Million 78
Lantheus Medical Imaging Completes Private Placement 9.75% Senior Notes For US$250 Million 79
Catalent Pharma Solutions Completes Private Placement Of Senior Notes Due 2018 For US$350 Million 80
Inverness Medical Innovations Completes Public Offering Of 7.88% Senior Notes For US$150 Million 81
Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million 82
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$700 Million 83
Valeant Pharma Completes Private Placement Of Senior Unsecured Notes For US$400 Million 84
Lantheus Medical Imaging Completes Private Placement Of 9.75% Senior Unsecured Notes For US$150 Million 85
Equity Offerings 86
Cerus Completes Underwritten Public Offering Of US$21 Million 86
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 88
MannKind Completes Public Offering Of Units For US$86 Million 90
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 92
WuXi PharmaTech Completes IPO Of US$167.7 Million 94
Alphatec Holdings Completes Underwritten Public Offering Of Common Stock For US$46 Million 96
DynaVox Completes IPO For US$140.6 Million 98
BioForm Medical Completes IPO Of US$92 Million 100
AcelRx Pharma Completes Underwriters' Exercise Of Over-Allotment Option For US$6 Million 101
Celldex Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For US$46 Million 103
Inverness Medical Innovations Completes Public Offering Of US$838.37 Million 105
Inverness Medical Innovations Completes Public Offering Of US$273.59 Million 107
Sagent Pharma Completes IPO Of US$106 Million 109
Sequenom Completes Public Offering Of US$96.6 Million 111
Power Medical Interventions Completes IPO Of US$42.35 Million 113
MannKind Completes Public Offering Of Shares For US$67 Million 114
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 116
Cytori Therapeutics Completes Exercise Of Underwriters’ Overallotment Option For US$21 Million 118
Celldex Therapeutics Completes Public Offering Of Shares For US$104 Million 120
Exact Sciences Completes Underwritten Public Offering Of US$69 Million 122
Medidata Solutions Completes IPO Of US$101.43 Million 124
athenahealth Completes IPO Of US$90 Million 126
Sequenom Completes Public Offering Of Common Stock For US$62 Million 128
Danaher Completes Public Offering Of Common Stock For US$996.18 Million 130
Celldex Therapeutics Completes An Underwritten Public Offering Of US$32 Million 132
OPKO Health Completes Exercise Of Underwriters’ Over-allotment Option For US$110 Million 134
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 136
Emdeon Completes IPO Of US$166.24 Million 138
AMAG Pharma Completes Public Offering Of US$162.85 Million 140
SEQUENOM Completes Private Placement Of Common Stock For US$51.6 Million 142
Mindray Medical International Completes Public Offering Of US$152.8 Million 144
Unilife Completes Public Offering Of Common Stock For US$20 Million 146
Unilife Completes Public Offering Of Common Stock For US$35.9 Million 147
Merger Deals 149
MSC Care Management Completes Merger With One Call Medical 149
Accelrys Completes Merger With Symyx Technologies 151
Private Equity 153
MSD Capital And North Peak Capital Acquire Dental One From SSM Partners And ABN Amro Cpaital 153
Citi Venture Capital Completes Acquisition Of Ness Technologies For US$307 Million 154
GTCR Acquires Sterigenics International From Silverfleet Capital And PPM America 156
Warburg Pincus Completes Acquisition Of ReSearch Pharma Services 158
HLTH Sells Porex To Aurora Capital 160
Huntsman Gay Global Acquires 51% Stake In Sunquest Information From Vista Equity Partners 161
JLL Partners Completes Acquisition Of American Dental Partners For US$398 Million 162
ABRY Partners Invests US$85 Million In Automated HealthCare Solutions 164
Venture Financing 165
Palmaz Scientific Raises Additional US$4.7 Million In Venture Financing Round 165
Palmaz Scientific Raises US$11 Million In Venture Financing Round 166
Appendix 167
Methodology 167
About GlobalData 167
Contact Us 167
Disclaimer 167

List of Tables
Jefferies and Company, Inc., Key Facts 1
Jefferies and Company, Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 1
Jefferies and Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 8
Jefferies and Company, Inc., Medical Equipment Deals Advised By Type, 2007 to YTD 2013 9
Jefferies and Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 10
Jefferies and Company, Inc. Deals Advised By Market, 2007 to YTD 2013 11
Jefferies and Company, Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 13
Sonova Holding Acquires Advanced Bionics 20
AMICAS Acquires Emageon 22
Baxter International Completes Acquisition Of Baxa For US$380 Million 23
Align Technology Completes Acquisition Of Cadent 25
Covidien Completes Acquisition Of Power Medical Interventions 28
Berwind Acquires Oliver Products, Developer Of Sterile Medical Device, From Mason Wells 30
Tunstall Healthcare Completes Acquisition Of American Medical Alert For US$82 Million 31
BioScrip Completes Acquisition Of Critical Homecare Solutions From Kohlberg and Company 33
MedAssets Completes The Acquisition Of Broadlane From TowerBrook 35
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 37
Baxter International Completes Acquisition Of Prism Pharma For US$338 Million 39
MedQuist And Cbay Complete The Acquisition Of Spheris 41
Nuance Communications Acquires eScription 43
Bausch and Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 45
Myriad Genetics Acquires Rules-Based Medicine 47
Philips Healthcare Acquires Discus Holdings 49
Dainippon Sumitomo Pharma Completes Acquisition Of Sepracor For US$2.6 Billion 50
General Dynamics Acquires ViPs From HLTH 52
AssuraMed Completes Acquisition Of Invacare Supply Group From Invacare For US$151 Million 53
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 55
Hologic Acquires Cytyc For US$6,200 Million 57
Roper Industries Completes Acquisition Of Sunquest Information Systems, Healthcare IT Company, For US$1.42 Billion 59
Pall Corporation Completes Acquisition Of ForteBio For US$142.5 Million 61
Hologic Acquires Biolucent 63
Automatic Data Processing Acquires AdvancedMD 64
The ConJoin Group Acquires PHNS 66
3M Company Completes Acquisition Of Arizant From Court Square Capital 67
Kimberly-Clark Completes Acquisition Of Pain Management Business From Baylis Medical Company 69
Trinity Biotech Completes Sale Of Coagulation Business To Diagnostica Stago 70
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For US$200 Million 72
Teleflex Completes Underwritten Public Offering Of 3.875% Convertible Senior Subordinated Notes For US$400 Million 73
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2017 For US$500 Million 75
RadNet Completes Private Placement Of 10.375% Senior Unsecured Notes For US$200 Million 77
Inverness Medical Innovations Completes Private Placement Of Senior Notes For US$100 Million 78
Lantheus Medical Imaging Completes Private Placement 9.75% Senior Notes For US$250 Million 79
Catalent Pharma Solutions Completes Private Placement Of Senior Notes Due 2018 For US$350 Million 80
Inverness Medical Innovations Completes Public Offering Of 7.88% Senior Notes For US$150 Million 81
Alere Completes Private Placement Of Senior Subordinate Notes For US$400 Million 82
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$700 Million 83
Valeant Pharma Completes Private Placement Of Senior Unsecured Notes For US$400 Million 84
Lantheus Medical Imaging Completes Private Placement Of 9.75% Senior Unsecured Notes For US$150 Million 85
Cerus Completes Underwritten Public Offering Of US$21 Million 86
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 88
MannKind Completes Public Offering Of Units For US$86 Million 90
Delcath Systems Completes Public Offering Of Common Stock For US$25.3 Million 92
WuXi PharmaTech Completes IPO Of US$167.7 Million 94
Alphatec Holdings Completes Underwritten Public Offering Of Common Stock For US$46 Million 96
DynaVox Completes IPO For US$140.6 Million 98
BioForm Medical Completes IPO Of US$92 Million 100
AcelRx Pharma Completes Underwriters' Exercise Of Over-Allotment Option For US$6 Million 101
Celldex Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For US$46 Million 103
Inverness Medical Innovations Completes Public Offering Of US$838.37 Million 105
Inverness Medical Innovations Completes Public Offering Of US$273.59 Million 107
Sagent Pharma Completes IPO Of US$106 Million 109
Sequenom Completes Public Offering Of US$96.6 Million 111
Power Medical Interventions Completes IPO Of US$42.35 Million 113
MannKind Completes Public Offering Of Shares For US$67 Million 114
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 116
Cytori Therapeutics Completes Exercise Of Underwriters’ Overallotment Option For US$21 Million 118
Celldex Therapeutics Completes Public Offering Of Shares For US$104 Million 120
Exact Sciences Completes Underwritten Public Offering Of US$69 Million 122
Medidata Solutions Completes IPO Of US$101.43 Million 124
athenahealth Completes IPO Of US$90 Million 126
Sequenom Completes Public Offering Of Common Stock For US$62 Million 128
Danaher Completes Public Offering Of Common Stock For US$996.18 Million 130
Celldex Therapeutics Completes An Underwritten Public Offering Of US$32 Million 132
OPKO Health Completes Exercise Of Underwriters’ Over-allotment Option For US$110 Million 134
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 136
Emdeon Completes IPO Of US$166.24 Million 138
AMAG Pharma Completes Public Offering Of US$162.85 Million 140
SEQUENOM Completes Private Placement Of Common Stock For US$51.6 Million 142
Mindray Medical International Completes Public Offering Of US$152.8 Million 144
Unilife Completes Public Offering Of Common Stock For US$20 Million 146
Unilife Completes Public Offering Of Common Stock For US$35.9 Million 147
MSC Care Management Completes Merger With One Call Medical 149
Accelrys Completes Merger With Symyx Technologies 151
MSD Capital And North Peak Capital Acquire Dental One From SSM Partners And ABN Amro Cpaital 153
Citi Venture Capital Completes Acquisition Of Ness Technologies For US$307 Million 154
GTCR Acquires Sterigenics International From Silverfleet Capital And PPM America 156
Warburg Pincus Completes Acquisition Of ReSearch Pharma Services 158
HLTH Sells Porex To Aurora Capital 160
Huntsman Gay Global Acquires 51% Stake In Sunquest Information From Vista Equity Partners 161
JLL Partners Completes Acquisition Of American Dental Partners For US$398 Million 162
ABRY Partners Invests US$85 Million In Automated HealthCare Solutions 164
Palmaz Scientific Raises Additional US$4.7 Million In Venture Financing Round 165
Palmaz Scientific Raises US$11 Million In Venture Financing Round 166

List of Figures
Jefferies and Company, Inc., Medical Equipment Deals Advised by Deal Type, 2007 to YTD 2013 1
Jefferies and Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 1
Jefferies and Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 1
Jefferies and Company, Inc., Medical Equipment Deals Advised By Market, 2007 to YTD 2013 1
Jefferies and Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 8
Jefferies and Company, Inc., Medical Equipment Deals Advised by Deal Type, 2007 to YTD 2013 9
Jefferies and Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 10
Jefferies and Company, Inc., Medical Equipment Deals Advised by Market, 2007 to YTD 2013 11

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

MicroPort Scientific Corporation (853) - Product Pipeline Analysis, 2014 Update

MicroPort Scientific Corporation (853) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • November 2014
  • by Global Data

Summary MicroPort Scientific Corporation (MicroPort) is a medical device manufacturer. The company develops, manufactures and markets products to treat vascular diseases and disorders. Its products include ...

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.